The Government's administration of the Pharmaceutical Benefits Scheme

17 August 2011

© Commonwealth of Australia 2011
ISBN 978-1-74229-511-4

View the report as a single document - (PDF 522KB)

---

View the report as separate downloadable parts:

MEMBERSHIP OF THE COMMITTEE	(PDF 11KB)
ABBREVIATIONS	(PDF 11KB)
RECOMMENDATIONS	(PDF 16KB)
Chapter 1 - Introduction	(PDF 14KB)
Terms of reference Conduct of the inquiry Acknowledgement Note on references Structure of the report Personal comment from the Chair - Declaration of interest
Chapter 2 - Background	(PDF 43KB)
The Pharmaceutical Benefits Scheme Memorandum of Understanding between the Commonwealth Government and Medicines Australia Announcement of listing deferrals
Chapter 3 - The Government's decision to defer the listing of medicines under the Pharmaceutical Benefits Scheme	(PDF 91KB)
Introduction The change to the administration of the PBS Impact of the change to the administration of the PBS Compliance with the intent of the Memorandum of Understanding Lack of consultation
Chapter 4 - Financial impact of the Pharmaceutical Benefits Scheme on the Commonwealth Budget	(PDF 62KB)
Introduction Overall costs and growth of the PBS Financial impact of the Government decision to defer listings Other possible savings measures
Chapter 5 - Consequences for patients	(PDF 125KB)
Introduction Financial impost Access to medicines Impact on health outcomes Benefits of effective treatment of medical conditions Consequences of not having access to the deferred medicines Committee comment
Chapter 6 - Consequences for the pharmaceutical sector and the availability of medicines in Australia	(PDF 77KB)
Introduction Consequences for companies Consequences for research and development Consequences for the availability of medicines in the Australian market
Chapter 7 - Conclusions and recommendations	(PDF 22KB)
Government senator's minority report	(PDF 60KB)
Introduction Process of listing medicines on the PBS Financial impact on the Commonwealth budget The Memorandum of Understanding with Medicines Australia A healthy pharmaceutical sector The Australian medicines market - available and accessible medicines Government senator's view
Australian Greens Additional Comments	(PDF 16KB)
Introduction Achieving lower priced generic medicines Evergreening of patents by originator companies Savings from change of prescriber habits
APPENDIX 1 - Submissions and additional information received by the committee	(PDF 11KB)
Submissions Additional information received
APPENDIX 2 - Public hearings and witnesses	(PDF 8KB)

For further information, contact:

Committee Secretary
Senate Standing Committees on Finance and Public Administration
PO Box 6100
Parliament House
Canberra ACT 2600
Australia

Phone:	+61 2 6277 3439
Fax:	+61 2 6277 5809
Email:	fpa.sen@aph.gov.au